Drugs / Rhamnose
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03962998 Comparator | Oct 2019 → Oct 2021 | small bowel Crohn disease | MediBeacon | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rhamnose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03962998 ↗ |
| Modality | Diagnostic / imaging agent | “dual sugar testing using lactulose and rhamnose for the assessment of gut permeability” NCT03962998 ↗ |